Topotecan Injection, Solution, Concentrate
Product Images NDC 0409-0302

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topotecan (NDC 0409-0302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Topotecan 01)

Chemical structure of Topotecan hydrochloride, as indicated by the molecular diagram showing the core ring systems, hydroxyl, methyl groups, and lactone moiety with an associated hydrochloride salt representation.*

FDA Label Image

Logo (Topotecan 02)

FDA Label Image

Principal Display Panel (4 mg/4 mL Vial Label)

Label for Topotecan Injection 1 mg/mL (4 mg/4 mL) sterile single-dose vial. The label includes storage instructions (2°C to 8°C), dilution requirement before intravenous infusion, and a caution for cytotoxicity. Distributed by Hospira, Inc., Lake Forest, IL, with NDC 0409-0302-01 and barcodes present.*

FDA Label Image

Principal Display Panel (4 mg/4 mL Vial Carton)

Topotecan Injection 4 mg/4 mL (1 mg/mL) single-dose vial packaging label from Hospira, Inc. The label includes dosing strength, storage instructions, and a caution that this is a cytotoxic agent. It states the product must be diluted before intravenous infusion and provides handling precautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.